B.Riley Financial Maintains Journey Medical(DERM.US) With Buy Rating, Raises Target Price to $9

Futu NewsNov 19 16:36 · Ratings

B. Riley Adjusts Journey Medical Price Target to $9 From $8, Maintains Buy Rating

MT NewswiresNov 18 21:51 · Ratings

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 15:13

US$9.75 - That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After These Results

Simply Wall StNov 15 20:57

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswireNov 15 05:10

Journey Medical Reports Q3 2024 Earnings, Eyes Emrosi Launch

TipRanksNov 14 12:01